- Home
- ADVM vs ANGH Comparison
ADVM vs ANGH Comparison
Compare ADVM & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- ANGH
- Stock Information
- Founded
- ADVM 2006
- ANGH 2012
- Country
- ADVM United States
- ANGH United Arab Emirates
- Employees
- ADVM N/A
- ANGH N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- ANGH Telecommunications Equipment
- Sector
- ADVM Health Care
- ANGH Consumer Discretionary
- Exchange
- ADVM Nasdaq
- ANGH Nasdaq
- Market Cap
- ADVM 47.4M
- ANGH 38.8M
- IPO Year
- ADVM 2014
- ANGH N/A
- Fundamental
- Price
- ADVM $2.25
- ANGH $0.51
- Analyst Decision
- ADVM Strong Buy
- ANGH
- Analyst Count
- ADVM 5
- ANGH 0
- Target Price
- ADVM $26.40
- ANGH N/A
- AVG Volume (30 Days)
- ADVM 186.4K
- ANGH 10.6K
- Earning Date
- ADVM 08-11-2025
- ANGH 06-30-2025
- Dividend Yield
- ADVM N/A
- ANGH N/A
- EPS Growth
- ADVM N/A
- ANGH N/A
- EPS
- ADVM N/A
- ANGH N/A
- Revenue
- ADVM $1,000,000.00
- ANGH $78,093,405.00
- Revenue This Year
- ADVM N/A
- ANGH N/A
- Revenue Next Year
- ADVM $18.82
- ANGH N/A
- P/E Ratio
- ADVM N/A
- ANGH N/A
- Revenue Growth
- ADVM N/A
- ANGH 88.72
- 52 Week Low
- ADVM $1.78
- ANGH $0.42
- 52 Week High
- ADVM $10.14
- ANGH $1.09
- Technical
- Relative Strength Index (RSI)
- ADVM 40.11
- ANGH 40.92
- Support Level
- ADVM $2.21
- ANGH $0.47
- Resistance Level
- ADVM $3.10
- ANGH $0.53
- Average True Range (ATR)
- ADVM 0.22
- ANGH 0.04
- MACD
- ADVM -0.00
- ANGH -0.00
- Stochastic Oscillator
- ADVM 4.49
- ANGH 16.72
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.